New Discovery Unveils Brain Inflammation as a Factor in Muscle Fatigue

Researchers at Washington University have discovered that brain inflammation can cause muscle dysfunction by releasing a protein that travels to the muscles, impairing their function. In experiments with fruit flies and mice, they found that this protein reduces energy production in muscle mitochondria. The research also identified possible ways to block this process, which could help treat or prevent muscle wasting in conditions like bacterial infections, Alzheimer’s, and long COVID. Credit: SciTechDaily

A study reveals that brain inflammation leads to the release of a protein that impairs muscle function, suggesting potential treatments for related muscle fatigue in diseases like Alzheimer’s and long COVID.

Infections and neurodegenerative diseases are known to cause brain inflammation. However, patients with brain inflammation often develop muscle problems that are seemingly independent of the central nervous system.

Now, researchers at Washington University School of Medicine in St. Louis have found that brain inflammation releases a specific protein that travels from the brain to the muscles, causing a decline in muscle function. The study, conducted with fruit flies and mice, has also identified ways to block this process. This could have significant implications for treating or preventing the muscle wasting often seen in inflammatory diseases such as bacterial infections, Alzheimer’s disease, and long COVID.

“We are interested in understanding the very deep muscle fatigue that is associated with some common illnesses,” said senior author Aaron Johnson, PhD, an associate professor of developmental biology. “Our study suggests that when we get sick, messenger proteins from the brain travel through the bloodstream and reduce energy levels in skeletal muscle. This is more than a lack of motivation to move because we don’t feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally.”

In their study, recently published in Science Immunology, the researchers investigated the effects of brain inflammation on muscle function by modeling three diseases: an E. coli bacterial infection, a SARS-CoV-2 viral infection, and Alzheimer’s. When the brain is exposed to inflammatory proteins characteristic of these diseases, damaging chemicals called reactive oxygen species build-up. The reactive oxygen species cause brain cells to produce an immune-related molecule called interleukin-6 (IL-6), which travels throughout the body via the bloodstream. The researchers found that IL-6 in mice — and the corresponding protein in fruit flies — reduced energy production in muscles’ mitochondria, the energy factories of cells.

Research from Washington University School of Medicine in St. Louis reveals how brain inflammation triggers extreme muscle weakness across several diseases, including viral infection, bacterial infection and Alzheimer’s disease. Shown are fruit fly muscles; the violet staining is a measure of how well mitochondria in muscle cells are producing energy. On the left is a healthy muscle, and on the right is a muscle exposed to IL-6, an immune-related molecule produced by the brain in response to infections or chronic disease. Credit: Shuo Yang

“Flies and mice that had COVID-associated proteins in the brain showed reduced motor function — the flies didn’t climb as well as they should have, and the mice didn’t run as well or as much as control mice,” Johnson said. “We saw similar effects on muscle function when the brain was exposed to bacterial-associated proteins and the Alzheimer’s protein amyloid beta. We also see evidence that this effect can become chronic. Even if an infection is cleared quickly, the reduced muscle performance remains many days longer in our experiments.”

Johnson, along with collaborators at the University of Florida and first author Shuo Yang, PhD — who did this work as a postdoctoral researcher in Johnson’s lab — make the case that the same processes are likely relevant in people. For instance, the bacterial brain infection meningitis is known to increase IL-6 levels and can be associated with muscle issues in some patients. Among COVID-19 patients, inflammatory SARS-CoV-2 proteins have been found in the brain during autopsy, and many long COVID patients report extreme fatigue and muscle weakness even long after the initial infection has cleared. Patients with Alzheimer’s disease also show increased levels of IL-6 in the blood as well as muscle weakness.